e.g. mhealth
Search Results (1 to 10 of 30 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 10 JMIR Cancer
- 7 JMIR Research Protocols
- 4 JMIRx Med
- 3 JMIR mHealth and uHealth
- 2 JMIR Public Health and Surveillance
- 2 Journal of Medical Internet Research
- 1 JMIR Aging
- 1 JMIR Formative Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Response: We agree with this suggestion and have added two new tables to present our results more clearly:
Table 1: Demographic and clinical characteristics of childhood cancer survivors (page 9).
Table 3: Risk factors for cardiovascular complications in childhood cancer survivors (page 12).
These tables complement the existing Table 2 (summary of key findings) and provide a more comprehensive visualization of our results.
2.
JMIRx Med 2025;6:e79672
Download Citation: END BibTex RIS
Peer Review of “Cardiotoxicity in Pediatric Cancer Survivorship: Retrospective Cohort Study”
This significant and timely manuscript [1], which investigates the long-term cardiovascular complications in pediatric cancer survivors, has notable strengths, including its large cohort size, long-term follow-up, and utilization of a well-established dataset (Childhood Cancer Survivor Study). The methodology is generally sound, and the findings contribute meaningfully to our understanding of cardiotoxicity risks in childhood cancer survivors.
JMIRx Med 2025;6:e79523
Download Citation: END BibTex RIS
Peer Review of “Cardiotoxicity in Pediatric Cancer Survivorship: Retrospective Cohort Study”
childhood cancer survivors survivors
JMIRx Med 2025;6:e79521
Download Citation: END BibTex RIS
Cardiotoxicity in Pediatric Cancer Survivorship: Retrospective Cohort Study
This study seeks to address critical gaps in our understanding of cardiotoxicity in pediatric cancer survivorship, aiming to improve the cardiovascular health and overall quality of life for childhood cancer survivors.
The primary aim of this study is to comprehensively investigate cardiotoxicity in pediatric cancer survivors using data from the Childhood Cancer Survivor Study (CCSS; Textbox 1).
JMIRx Med 2025;6:e65299
Download Citation: END BibTex RIS
Survivors of many common early-stage cancers are now more likely to die of cardiovascular disease than cancer, elevating the importance of addressing cardiovascular health (CVH) in routine survivorship care [1-6]. Over 90% of survivors have multiple cardiovascular risk factors [7], increasing their risk of both poor cardiovascular and cancer outcomes [8-16]. Compared to the general population, survivors of cancer have poorer CVH [17,18].
J Med Internet Res 2025;27:e65152
Download Citation: END BibTex RIS
However, no intervention customized to address FCR in survivors of CRC has been developed [7,41].
In summary, this paper describes the process of adapting i Conquer Fear into TG-i Conquer Fear targeting survivors of CRC.
JMIR Cancer 2025;11:e63486
Download Citation: END BibTex RIS
In addition, cancer survivors have been particularly vulnerable to COVID-19 during the pandemic [16]. The greater risk of health consequences for cancer survivors due to the COVID-19 pandemic, combined with evidence gaps in the existing survivorship literature [17], demonstrates a critical need to better understand the mechanisms of health behavior and risk perceptions during survivorship.
JMIR Res Protoc 2024;13:e48516
Download Citation: END BibTex RIS
Hence, for many cancer survivors, obesity poses a dual risk of decreased cardiometabolic health and increased cancer recurrence.
In the United States, there were an estimated 18 million cancer survivors in 2022 [7], and this number is expected to increase to 22.5 million by 2032 due to advancements in treatment and early detection [8]. It is estimated that 32.5% of cancer survivors are overweight or obese [7].
JMIR Res Protoc 2024;13:e54126
Download Citation: END BibTex RIS
Characteristics of survivors diagnosed with a first primary cancer in 2009-2010 at age ≥18 years among 5-year survivors in South Korea.
Risk of developing any type of subsequent primary cancer (SPC) among 5-year cancer survivors with their first diagnosis between 2009 and 2010 in South Korea.
a SIR: standardized incidence ratio.
b FPC: first primary cancer.
JMIR Public Health Surveill 2024;10:e48380
Download Citation: END BibTex RIS
Consequently, the growing number of lung cancer survivors underscores the urgent need to address posttreatment needs.
Surviving lung cancer can substantially impact the quality of life and emotional health [4-6]. Many survivors adjust over time; however, persistent fear and the expectation of a rapid return to normal posttreatment life are common [7,8].
JMIR Res Protoc 2024;13:e54707
Download Citation: END BibTex RIS